146 related articles for article (PubMed ID: 25062418)
1. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
[TBL] [Abstract][Full Text] [Related]
2. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
[TBL] [Abstract][Full Text] [Related]
3. Fas gene promoter polymorphisms in primary Sjögren's syndrome.
Mullighan CG; Heatley S; Lester S; Rischmueller M; Gordon TP; Bardy PG
Ann Rheum Dis; 2004 Jan; 63(1):98-101. PubMed ID: 14672901
[TBL] [Abstract][Full Text] [Related]
4. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
5. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
[TBL] [Abstract][Full Text] [Related]
6. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
[TBL] [Abstract][Full Text] [Related]
7. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort.
Márka M; Bessenyei B; Zeher M; Semsei I
Scand J Immunol; 2005 Nov; 62(5):474-80. PubMed ID: 16305644
[TBL] [Abstract][Full Text] [Related]
8. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.
Pertovaara M; Antonen J; Hurme M
Ann Rheum Dis; 2006 May; 65(5):666-70. PubMed ID: 16166103
[TBL] [Abstract][Full Text] [Related]
9. Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.
Bolstad AI; Wargelius A; Nakken B; Haga HJ; Jonsson R
J Rheumatol; 2000 Oct; 27(10):2397-405. PubMed ID: 11036836
[TBL] [Abstract][Full Text] [Related]
10. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin KM and GM gene polymorphisms modify the clinical presentation of primary Sjögren's syndrome.
Pertovaara M; Hurme M; Antonen J; Pasternack A; Pandey JP
J Rheumatol; 2004 Nov; 31(11):2175-80. PubMed ID: 15517630
[TBL] [Abstract][Full Text] [Related]
12. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome.
Ittah M; Gottenberg JE; Proust A; Hachulla E; Puechal X; Loiseau P; Mariette X; Miceli-Richard C
Genes Immun; 2005 Aug; 6(5):457-8. PubMed ID: 15933742
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
14. TNFR1-383 A˃C polymorphism association with clinical manifestations in primary Sjögren's syndrome patients.
Fletes-Rayas AL; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Oregon-Romero E
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323176
[TBL] [Abstract][Full Text] [Related]
15. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.
Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2001 Jun; 40(6):656-61. PubMed ID: 11426023
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M; Pöllänen P; Lehtimäki T
Rheumatology (Oxford); 2004 Dec; 43(12):1476-9. PubMed ID: 15316122
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome.
Cay HF; Sezer I; Dogan S; Felek R; Aslan M
Clin Exp Rheumatol; 2012; 30(6):843-9. PubMed ID: 22703762
[TBL] [Abstract][Full Text] [Related]
18. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
[TBL] [Abstract][Full Text] [Related]
19. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?
Sellam J; Miceli-Richard C; Gottenberg JE; Proust A; Ittah M; Lavie F; Loiseau P; Mariette X
Rheumatology (Oxford); 2008 Apr; 47(4):437-41. PubMed ID: 18296721
[TBL] [Abstract][Full Text] [Related]
20. Analysis of IL10 haplotypes in primary Sjögren's syndrome patients from Western Mexico: Relationship with mRNA expression, IL-10 soluble levels, and autoantibodies.
Vázquez-Villamar M; Palafox-Sánchez CA; Muñoz-Valle JF; Valle Y; Orozco-Barocio G; Hernández-Bello J; Oregon-Romero E
Hum Immunol; 2015 Jul; 76(7):473-9. PubMed ID: 26074416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
